Treatment of Tinea Corporis
The recommended first-line treatment for tinea corporis is topical terbinafine 1% cream applied once daily for 1-2 weeks. 1
Diagnosis
Before initiating treatment, proper diagnosis is essential:
- Confirm diagnosis through microscopic examination (KOH preparation) or fungal culture 1, 2, 3
- Clinical presentation typically includes well-demarcated, circular or oval, erythematous, scaly patches or plaques with raised borders 3
- Dermoscopy can be a useful non-invasive diagnostic tool 3
Treatment Algorithm
Step 1: Topical Therapy (First-Line)
- Terbinafine 1% cream once daily for 1-2 weeks 1
- Alternative options:
Step 2: Systemic Therapy (For extensive, resistant, or recurrent cases)
- Terbinafine 250mg daily for 1-2 weeks (particularly effective for Trichophyton species) 1, 5
- Itraconazole 100-200mg daily for 2-4 weeks (effective for both Trichophyton and Microsporum species) 1
- Griseofulvin 500mg daily (adults) or 10mg/kg daily (children) for 2-4 weeks 1, 2
- Particularly effective for Microsporum species infections 1
Treatment Duration and Follow-up
- Continue treatment for at least one week after clinical resolution of symptoms 1, 6
- For topical therapy: 2 weeks is typically sufficient 6
- For systemic therapy: 2-4 weeks depending on the agent and severity 1, 2, 5
- The endpoint of treatment should be mycological cure, not just clinical improvement 1
Important Considerations
Efficacy
- Topical terbinafine and naftifine have demonstrated superior efficacy compared to placebo in achieving clinical and mycological cure 4
- Oral terbinafine, itraconazole, and fluconazole have all shown effectiveness in treating tinea corporis 5
Cautions
- Avoid combination antifungal/corticosteroid preparations, especially in children, as they may lead to persistent or recurrent infections 7
- Topical steroids can modify the clinical appearance, making diagnosis more difficult 3
Prevention of Reinfection
- Screen and treat all household members for anthropophilic infections 1
- Disinfect personal items (combs, brushes) and avoid sharing them 1
- Apply antifungal powders containing miconazole or clotrimazole to prevent reinfection 1
Special Populations
Children
- Topical agents are generally preferred as first-line therapy 1, 7
- For systemic therapy, griseofulvin (10mg/kg daily) is well-tolerated with extensive safety data in children 1, 2
Extensive or Resistant Cases
- Oral itraconazole has shown superior efficacy (66% cure rate) compared to fluconazole (42%), terbinafine (28%), and griseofulvin (14%) in treatment-resistant cases 1
Remember that accurate diagnosis is crucial before initiating treatment, and therapy should continue until complete eradication of the infecting organism as indicated by appropriate clinical or laboratory examination 2, 3.